Literature DB >> 1597188

Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase.

A Schieber1, R W Frank, S Ghisla.   

Abstract

Prostaglandin 9-ketoreductase (PG-9-KR) was purified from pig kidney to homogeneity, as judged by SDS/PAGE using an improved procedure. The enzyme is pro-S stereoselective with regard to hydrogen transfer from NADPH with prostaglandin E2 as substrate and reduces its 9-keto group with approximately 90% stereoselectivity to form prostaglandin F2 alpha. Approximately 8% of the prostaglandin F formed has the beta-configuration. In addition to catalyzing the interconversion of prostaglandin E2 to F2 alpha, PG-9-KR also oxidizes prostaglandin E2, F2 alpha and D2 to their corresponding, biologically inactive, 15-keto metabolites. Incubation of PG-9-KR with prostaglandin F2 alpha and NAD+ leads to the preferential formation of 15-keto prostaglandin F2 alpha rather than prostaglandin E2. This suggests that the prostaglandin E2/prostaglandin F2 alpha ratio is not determined by the NADP+/NADPH redox couple. The enzyme also reduces various other carbonyl compounds (e.g. 9,10-phenanthrenequinone) with high efficiency. The catalytic properties measured for PG-9-KR suggest that its in vivo function is unlikely to be to catalyze formation of prostaglandin F2 alpha. The monomeric enzyme has a molecular mass of 32 kDa and exists as four isoforms, as judged by isoelectric focusing. PG-9-KR contains 1.9 mol Zn2+/mol enzyme and no other cofactors. Human kidney PG-9-KR was also purified to homogeneity. The human enzyme has a molecular mass of 34 kDa and also exists as four isoforms. Polyclonal antibodies raised against pig kidney PG-9-KR cross-react with human kidney PG-9-KR and also with human brain carbonyl reductase, as demonstrated by Western blot analysis. Sequence data of tryptic peptides from pig kidney PG-9-KR show greater than 90% identity with human placenta carbonyl reductase. From comparison of several properties (catalytical, structural and immunological properties), it is concluded that PG-9-KR and carbonyl reductase are identical enzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597188     DOI: 10.1111/j.1432-1033.1992.tb16952.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Functional characterization of the promoter of carbonyl reductase 1 gene in porcine endometrial cells.

Authors:  Ai-Ling Zhang; Xian-Yue Sun; Qi Yin; Jian-Hua Zeng; Zhe Zhang; Jia-Qi Li; Hao Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2017-07       Impact factor: 3.066

Review 2.  Physiological aspects of pig kidney xenotransplantation and implications for management following transplant.

Authors:  Christophe Hansen-Estruch; David K C Cooper; Eric Judd
Journal:  Xenotransplantation       Date:  2022-03-16       Impact factor: 3.788

3.  Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults.

Authors:  Todd A Trappe; Robert A Standley; Bozena Jemiolo; Chad C Carroll; Scott W Trappe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-05       Impact factor: 3.619

4.  Estradiol-17beta, prostaglandin E2 (PGE2), and the PGE2 receptor are involved in PGE2 positive feedback loop in the porcine endometrium.

Authors:  Agnieszka Waclawik; Henry N Jabbour; Agnieszka Blitek; Adam J Ziecik
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

5.  Carboxyethyllysine in a protein: native carbonyl reductase/NADP(+)-dependent prostaglandin dehydrogenase.

Authors:  M Krook; D Ghosh; R Strömberg; M Carlquist; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

6.  Malignant ovarian tumors with induced expression of carbonyl reductase show spontaneous regression.

Authors:  Hui Wang; Yoshihito Yokoyama; Shigeki Tsuchida; Hideki Mizunuma
Journal:  Clin Med Insights Oncol       Date:  2012-02-09

7.  Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer.

Authors:  M Umemoto; Y Yokoyama; S Sato; S Tsuchida; F Al-Mulla; Y Saito
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

Review 8.  Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer.

Authors:  Kouji Banno; Miho Iida; Megumi Yanokura; Haruko Irie; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  ScientificWorldJournal       Date:  2015-02-03

Review 9.  The Biosynthesis of Enzymatically Oxidized Lipids.

Authors:  Ali A Hajeyah; William J Griffiths; Yuqin Wang; Andrew J Finch; Valerie B O'Donnell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-19       Impact factor: 5.555

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.